Quipt Home Medical Corp.

  • Market Cap: Small Cap
  • Industry: Miscellaneous
  • ISIN: CA74880P1045
CAD
3.45
0.11 (3.29%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

15.8 k

Shareholding (Mar 2025)

FII

57.17%

Held by 159 FIIs

DII

41.75%

Held by 4 DIIs

Promoter

0.57%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

The company has declared negative results for the last 8 consecutive quarters

  • The company has declared negative results in Mar 23 after 4 consecutive negative quarters
  • ROCE(HY) Lowest at -9.96%
  • INTEREST COVERAGE RATIO(Q) Lowest at 415.29
  • INVENTORY TURNOVER RATIO(HY) Lowest at 4.84%
2

Risky -

3

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

CAD 159 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.68

stock-summary
Return on Equity

-9.44%

stock-summary
Price to Book

1.14

Revenue and Profits:
Net Sales:
81 Million
(Quarterly Results - Jun 2025)
Net Profit:
-4 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.96%
0%
-4.96%
6 Months
39.68%
0%
39.68%
1 Year
-8.73%
0%
-8.73%
2 Years
-45.24%
0%
-45.24%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Quipt Home Medical Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
30.17%
EBIT Growth (5y)
-0.08%
EBIT to Interest (avg)
0.31
Debt to EBITDA (avg)
1.19
Net Debt to Equity (avg)
0.67
Sales to Capital Employed (avg)
1.20
Tax Ratio
2.20%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
71.71%
ROCE (avg)
3.85%
ROE (avg)
3.70%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.09
EV to EBIT
-102.70
EV to EBITDA
4.10
EV to Capital Employed
1.05
EV to Sales
0.75
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1.03%
ROE (Latest)
-9.44%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 3 Schemes (0.51%)

Foreign Institutions

Held by 159 Foreign Institutions (57.17%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -2.89% vs 2.59% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -90.91% vs -57.14% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "80.70",
          "val2": "83.10",
          "chgp": "-2.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "12.90",
          "val2": "16.30",
          "chgp": "-20.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.10",
          "val2": "3.20",
          "chgp": "-3.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.40",
          "val2": "-0.10",
          "chgp": "-300.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-4.20",
          "val2": "-2.20",
          "chgp": "-90.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-32.90%",
          "val2": "13.10%",
          "chgp": "-4.60%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Sep 2024 is 17.20% vs 59.76% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Sep 2024 is -142.11% vs -161.29% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "334.60",
          "val2": "285.50",
          "chgp": "17.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "65.50",
          "val2": "56.50",
          "chgp": "15.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "12.60",
          "val2": "10.30",
          "chgp": "22.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.10",
          "val2": "-1.80",
          "chgp": "-16.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-9.20",
          "val2": "-3.80",
          "chgp": "-142.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.40%",
          "val2": "27.40%",
          "chgp": "-1.30%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
80.70
83.10
-2.89%
Operating Profit (PBDIT) excl Other Income
12.90
16.30
-20.86%
Interest
3.10
3.20
-3.13%
Exceptional Items
-0.40
-0.10
-300.00%
Consolidate Net Profit
-4.20
-2.20
-90.91%
Operating Profit Margin (Excl OI)
-32.90%
13.10%
-4.60%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is -2.89% vs 2.59% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -90.91% vs -57.14% in Jun 2024

Annual Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
334.60
285.50
17.20%
Operating Profit (PBDIT) excl Other Income
65.50
56.50
15.93%
Interest
12.60
10.30
22.33%
Exceptional Items
-2.10
-1.80
-16.67%
Consolidate Net Profit
-9.20
-3.80
-142.11%
Operating Profit Margin (Excl OI)
14.40%
27.40%
-1.30%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Sep 2024 is 17.20% vs 59.76% in Sep 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Sep 2024 is -142.11% vs -161.29% in Sep 2023

stock-summaryCompany CV
About Quipt Home Medical Corp. stock-summary
stock-summary
Quipt Home Medical Corp.
Miscellaneous
Protech Home Medical Corp., formerly Patient Home Monitoring Corp. is a healthcare service company. The Company is engaged in providing in-home monitoring equipment, supplies and services to patients in the United States. It operates through three segments: Viemed, PHM and Corporate. The Viemed segment is a Medicare durable medical equipment supplier that provides non-invasive ventilation equipment and services across the nation. The PHM segment provides in-home monitoring and disease management services for patients in the United States healthcare market. It offers services, such as respiratory disease management, including chronic obstructive pulmonary disease; equipment solutions; in-home sleep testing; sleep apnea and positive airway pressure treatment; oxygen therapy; respiratory equipment rental, and international normalized ratio (INR) self-testing. The Viemed segment has operations throughout the Central and Southern United States.
Company Coordinates stock-summary
Company Details
1019 TOWN DRIVE , WILDER KY : 41076
Registrar Details